FDA greenlights Lilly obesity pill as Novo heats up race
US regulators have approved Eli Lilly’s new obesity pill, escalating the already fierce GLP-1 weight-loss race where Novo Nordisk has been gaining ground. The s...
#Eli Lilly
All topics tagged with #Eli Lilly
Eli Lilly’s $6.3B Centessa Deal Signals Sleep Drug Race
Eli Lilly is reportedly acquiring sleep-drug maker Centessa for $6.3B, underscoring how aggressively big pharma is moving to secure differentiated CNS and sleep...